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Abstract
Goodpasture disease (GD) is a rare autoimmune disorder characterized by the development of pathologic
autoantibodies against both glomerular and alveolar basal membranes. Approximately one third of the
patients with GD are also positive for anti-neutrophil cytoplasmic antibody (ANCA). In this case report, a
74-year-old woman was diagnosed as having myeloperoxidase (MPO)-ANCA-positive GD with severe aortic
valve stenosis (AS). She underwent immunosuppressive therapy and plasmapheresis that led to GD remission.
Whether a cardiac surgery affects a MPO-ANCA-positive GD in remission is unknown. We reported the
outcomes after aortic valve replacement for severe AS in a patient with MPO-ANCA-positive GD.
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Background
Anti-glomerular basement membrane (GBM) disease or
Goodpasture disease (GD) is an autoantibody-mediated
autoimmune small vessel vasculitis that generally
presents as a pulmonary–renal syndrome. This rare
disease has an annual incidence of 0.5–1 case per
million and demonstrates a bimodal age distribution [1].
Up to one third of patients with anti-GBM disease are
also positive for anti-neutrophil cytoplasmic antibody
(ANCA), mainly with specificity to myeloperoxidase
(MPO). While anti-GBM disease is generally considered
a non-relapsing illness, ANCA-positive small vessel
vasculitis has a relevant risk of relapse that demands
maintenance therapy after induction of remission [2].
The factors that affect a MPO-ANCA-positive GD in
remission period are unknown.
In this case report, we describe the outcomes after
aortic valve replacement (AVR) for severe aortic
valve stenosis (AS) in a 74-year-old woman with
MPO-ANCA-positive GD.
Case presentation
A 74-year-old woman presented with cough, hemosputum,
exacerbation of exertional dyspnea, appetite loss, and
fatigue. She had a previous history of hypertension. On
physical examination, inspiratory crackles in both lower
lungs and a Levine III/VI systolic murmur on the second
left sternal border were present. Blood tests showed mark-
edly raised creatinine (1022 μmol/l), low hemoglobin
(7.3 g/dl), low albumin (2.5 g/dl), high KL-6 (574 U/ml;
normal <500 U/ml) (Fig. 1), positive anti-GBM antibody
(73 U/ml; normal <3.0 U/ml), positive MPO-ANCA
(233 U/ml; normal <3.5 U/ml) (Fig. 1), and high C-react-
ive protein (1.65 mg/dl; normal <0.21 mg/dl). She was ad-
mitted and received further examination.
Chest radiograph showed bilateral patchy pulmonary
infiltrates in the middle and lower lung field. Atypical
honeycomb lung was noted significantly in the
subpleural portion and lower field of the lung on computed
tomography (CT). CT finding showed usual interstitial
pneumonia (IP) pattern. Transthoracic echocardiography
demonstrated severe AS. Renal biopsy exhibited a necrotiz-
ing crescentic glomerulonephritis in the pathological
examination. Acute renal failure was considered to be
caused by rapidly progressive glomerulonephritis. She
was diagnosed as having MPO-ANCA-positive GD
with severe AS. Pulsed immunosuppressive therapy
using methylprednisolone and plasmapheresis were
performed immediately. These therapies improved her
respiratory condition but did not improve her renal
dysfunction. Maintenance dialysis was then intro-
duced. Anti-GBM antibody and MPO-ANCA value
dropped to 23 and 5.9 U/ml (Fig. 1), and the general
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condition of the patient improved. Therefore, she was
discharged after about 2 months of hospitalization.
Methylprednisolone pulses followed by prednisone
was tapered up to 5 mg/day for a year, and MPO-
ANCA-positive GD was considered to be in remis-
sion. She was introduced to the Department of
Cardiovascular Surgery in our hospital for AS treatment.
Physical examination at the time of admission indi-
cated a regular pulse of 82 beats/min, blood pressure of
130/80 mmHg, and a Levine III/VI systolic murmur on
the second left sternal border. Chest radiography showed
a cardiothoracic ratio of 63 % and bilateral infiltration
shadow (Fig. 2a). His blood test results are as follows:
creatinine, 302 μmol/l; hemoglobin, 9.9 g/dl; albumin,
3.8 g/dl; KL-6, 720 U/ml (Fig. 1); anti-GBM antibody,
0.9 U/ml; MPO-ANCA, 0.6 U/ml (Fig. 1); and C-reactive
protein, 0.13 mg/dl.
The electrocardiogram showed sinus rhythm and ST de-
pression with strain pattern in the I, aVL, and V5–V6
leads, which indicated left ventricular hypertrophy. Trans-
thoracic echocardiography demonstrated an ejection
fraction of 76 %. The left ventricular end-diastolic/end-
systolic dimension, peak/mean pressure gradient through
the aortic valve, and aortic valve area were 52/29 mm,
152/95 mmHg, and 0.76 cm2, respectively. Severe AS was
recognized. Coronary angiography confirmed no signifi-
cant stenosis in the coronary artery. Abnormal pressure
value was absent in the right heart catheter test. The car-
diac output and cardiac index were 6.4 and 4.5 l/min/m2,
respectively. CT indicated usual IP pattern in the lung
(Fig. 2b, c). The vital capacity (VC), %VC, forced VC, and
FEV 1.0 % in the pulmonary function test were 2.07 l,
92 %, 2.08 l, and 86 %, respectively. Blood gas analysis
(BGA) in the room air indicated a pH of 7.37, PO2 of
89.8 mmHg, and PCO2 of 42.9 mmHg. Lung function was
maintained in the lower limit of normal.
After consultation with an anesthesiologist and a
pulmonologist about her condition, we determined that
cardiac surgery could be performed because GS and IP
were considered inactive based on the data.
Surgery was performed through median sternotomy.
Betamethasone (235 mg) was used upon initiation of
Fig. 1 Preoperative and postoperative course in MPO-ANCA, anti-GBM-antibody, and KL-6. The patient received immunosuppressive therapy and
plasmapheresis for MPO-ANCA-positive GD before 18 M prior to AVR. MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, anti-GBM-antibody
anti-glomerular basement membrane antibodies, AVR aortic valve replacement, GD Goodpasture disease, M months
Fig. 2 a Chest radiography 1 month before AVR. Chest radiography showed a cardiothoracic ratio of 63 % and bilateral infiltration shadow.
b CT findings of the right lower fields of the lung. c CT findings of the left lower fields of the lung. CT indicated usual interstitial pneumonia
pattern. AVR aortic valve replacement, CT computed tomography
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cardiopulmonary bypass (CPB). CPB was established via
an ascending aortic cannulation and right atrium
drainage. A venting tube was placed in the left atrium
through the right superior pulmonary vein. After cardiac
arrest, aortotomy was performed. The aortic valve was
tricuspid and severely calcified. A 21-mm Carpentier-
Edwards PERIMOUNT (CEP) Magna Ease pericardial
prosthesis (Edwards Lifesciences, Irvine, CA, USA) was
implanted after valve excision. The patient was weaned
off cardiopulmonary support uneventfully. Intraoperative
administration of hydrocortisone sodium succinate
(200 mg) and red cell concentrates (560 ml) was carried
out. The CPB time and operative time were 75 and
148 min, respectively. She was extubated two and a half
hours after the operation.
She could be discharged at postoperative day 15 without
GD relapse and IP exacerbation. Her condition was stable
1 year after the AVR. Her blood tests showed KL-6 of
578 U/m (Fig. 1), anti-GBM antibody of 1.0 U/ml, and
MPO-ANCA of 2.0 U/ml (Fig. 1). Exacerbation findings
were not confirmed in chest radiograph (Fig. 3). The
patient continued to take 5 mg of prednisone daily.
Discussion
Anti-GMB disease is a rare autoimmune disorder.
The antigenic epitope within the non-collagenous-1
(α3 NCI) domain of type IV collagen in the GBM is
well defined, and the confined expression of this
collagen to glomerular and alveolar basement membrane
leads to organ specificity of the disease. The deposition of
anti-GBM antibody in glomerular and alveolar basement
membranes induces glomerulonephritis and pulmonary
hemorrhage [1, 3].
On the other hand, ANCA-associated systemic vascu-
litis, which is characterized by necrotizing inflammation
of the small vessels, is closely related to ANCA directed
to proteinase-3 or to MPO [4]. About 5 % of ANCA-
positive patients have positive anti-GBM antibody, and
32 % of anti-GBM antibody-positive patients also have
positive ANCAs. Furthermore, 82 % of patients with
both antibodies have MPO-ANCA [5].
Double-positive (both anti-GBM antibody and ANCA
antibody positive) patients have higher relapse rate than
those with anti-GBM antibody alone [1]. This result is
attributed to ANCA-positive small vessel vasculitis,
which has a risk of relapse after induction of remission
[2]. In this case, performing an AVR is considered
difficult because of the possibility of MPO-ANCA-
positive GD recurrence. Both genetic and environmental
factors, such as hydrocarbon exposure, smoking, extra-
corporeal lithotripsy, virus, and Clostridium botulinum,
are implicated in the development of anti-GBM disease
[6]. However, factors that exacerbate GD are unknown.
Fortunately, AVR used by CPB did not affect the patient
with MPO-ANCA-positive GD in remission.
Etter et al. [7] reported that antibodies to human
lysosomal membrane protein 2 (hLAMP2) could be an
early indicator of double-positive GS relapse. Measuring
anti-hLAMP2 antibody as well as anti-GBM antibody
and ANCA antibody can be helpful in the long-term
follow-up of patients.
Whether the IP was idiopathic or secondary due to
double-positive GD in this case is unclear; thus, predict-
ing how the IP is affected by the AVR is difficult. Prior
to the operation, KL-6 was 720 U/ml, BGA was normal,
and the lung function of the patient was maintained in
the lower limit of normal. In consultation with the
pulmonologist, we determined that surgery could be
performed. Risk factors for acute exacerbation of IP are
also unknown. The acute exacerbation of IP can cause
death, particularly in those with honeycomb lung.
Tanaka et al. [8] reported that performing endotracheal
intubation without using a muscle relaxant is important.
They also reported that postoperative care using a
ventilator should also be performed while maintaining a
low airway pressure and the PaO2 at ~80 Torr when
total arch replacement is performed for aortic arch
replacement with chronic IP.
Similarly, postoperative management by using a
ventilator in this case maintained a low airway pressure
and the PaO2 at ~80 Torr. In addition, intraoperative
administration of 200 mg of hydrocortisone sodium
succinate as steroid cover was performed. These
attempts may help prevent exacerbation of GD and IP.
Fig. 3 Chest radiography 12 months after AVR. Exacerbation findings
were not confirmed in chest radiograph 12 months after AVR. AVR
aortic valve replacement
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Conclusions
This may be the first case demonstrating AVR with
MPO-ANCA-positive GD. Based on the clinical findings,
the GD and IP were in remission and inactive phase.
Therefore, good early- and long-term results were
obtained. However, the risk factors that exacerbate GS
and IP remain unknown, and the possibility of GS
relapse is present. Close follow-up is needed in the future.
Consent
Written informed consent was obtained from the
patient for publication of this case report and any
accompanying images.
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